Leveraging crowdsourcing to facilitate the discovery of new medicines.
Gloomy predictions about the future of pharma have forced the industry to investigate alternative models of drug discovery. Public-private partnerships (PPPs) have the potential to revitalize the discovery and development of first-in-class therapeutics. The new PPP Arch2POCM hopes to foster biomedic...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2011
|
| _version_ | 1826299414934716416 |
|---|---|
| author | Norman, T Bountra, C Edwards, A Yamamoto, K Friend, S |
| author_facet | Norman, T Bountra, C Edwards, A Yamamoto, K Friend, S |
| author_sort | Norman, T |
| collection | OXFORD |
| description | Gloomy predictions about the future of pharma have forced the industry to investigate alternative models of drug discovery. Public-private partnerships (PPPs) have the potential to revitalize the discovery and development of first-in-class therapeutics. The new PPP Arch2POCM hopes to foster biomedical innovation through precompetitive validation of pioneer therapeutic targets for human diseases. In this meeting report, we capture insights garnered from the April 2011 Arch2POCM conference. |
| first_indexed | 2024-03-07T05:01:35Z |
| format | Journal article |
| id | oxford-uuid:d877097f-a344-41a8-9ef5-9ed0faea7bb2 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:01:35Z |
| publishDate | 2011 |
| record_format | dspace |
| spelling | oxford-uuid:d877097f-a344-41a8-9ef5-9ed0faea7bb22022-03-27T08:48:48ZLeveraging crowdsourcing to facilitate the discovery of new medicines.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d877097f-a344-41a8-9ef5-9ed0faea7bb2EnglishSymplectic Elements at Oxford2011Norman, TBountra, CEdwards, AYamamoto, KFriend, SGloomy predictions about the future of pharma have forced the industry to investigate alternative models of drug discovery. Public-private partnerships (PPPs) have the potential to revitalize the discovery and development of first-in-class therapeutics. The new PPP Arch2POCM hopes to foster biomedical innovation through precompetitive validation of pioneer therapeutic targets for human diseases. In this meeting report, we capture insights garnered from the April 2011 Arch2POCM conference. |
| spellingShingle | Norman, T Bountra, C Edwards, A Yamamoto, K Friend, S Leveraging crowdsourcing to facilitate the discovery of new medicines. |
| title | Leveraging crowdsourcing to facilitate the discovery of new medicines. |
| title_full | Leveraging crowdsourcing to facilitate the discovery of new medicines. |
| title_fullStr | Leveraging crowdsourcing to facilitate the discovery of new medicines. |
| title_full_unstemmed | Leveraging crowdsourcing to facilitate the discovery of new medicines. |
| title_short | Leveraging crowdsourcing to facilitate the discovery of new medicines. |
| title_sort | leveraging crowdsourcing to facilitate the discovery of new medicines |
| work_keys_str_mv | AT normant leveragingcrowdsourcingtofacilitatethediscoveryofnewmedicines AT bountrac leveragingcrowdsourcingtofacilitatethediscoveryofnewmedicines AT edwardsa leveragingcrowdsourcingtofacilitatethediscoveryofnewmedicines AT yamamotok leveragingcrowdsourcingtofacilitatethediscoveryofnewmedicines AT friends leveragingcrowdsourcingtofacilitatethediscoveryofnewmedicines |